Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists.

作者: W M H Behan , T W Stone

DOI: 10.1038/SJ.BJP.0704613

关键词: Quinolinic acidAntioxidantExcitotoxicityEndocrinologyXanthineNitric oxideInternal medicineKynurenic acidXanthine oxidaseChemistryNeurotoxicity

摘要: 1. Quinolinic acid may be an important endogenous excitotoxin, but its concentrations in brain are low. We have therefore attempted to determine whether neurotoxicity can increased by the simultaneous presence of free radicals. 2. was injected into hippocampus anaesthetized rats at doses 40 and 80 nmols which produced little neuronal loss, 120 over 90% loss. 3. A mixture xanthine oxidase, a known source radical reactive oxygen species, also generated damage alone, killed 80% CA1 neurons when combined with quinolinic acid. Similarly, nitric oxide donor S-nitroso-N-acetylpenicillamine (SNAP) potentiated 4. The glutamate antagonist 5,7-dichlorokynurenic prevented acid, not that plus xanthine/xanthine indicating simply result enhancement NMDA receptor activation. 5. Three chemically dissimilar antagonists adenosine A(2A) receptors caused oxidase or SNAP. 6. It is concluded species potentiate site interaction probably distal receptor. Blockade protect against this damage, suggesting potential value prevention damage.

参考文章(69)
Luísa V. Lopes, Rodrigo A. Cunha, J. A. Ribeiro, Cross Talk Between A1 and A2A Adenosine Receptors in the Hippocampus and Cortex of Young Adult and Old Rats Journal of Neurophysiology. ,vol. 82, pp. 3196- 3203 ,(1999) , 10.1152/JN.1999.82.6.3196
Melvyn P. HEYES, Cristian L. ACHIM, Clayton A. WILEY, Eugene O. MAJOR, Kuniaki SAITO, Sanford P. MARKEY, Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochemical Journal. ,vol. 283, pp. 595- 597 ,(1992) , 10.1042/BJ3200595
T W Stone, Neuropharmacology of quinolinic and kynurenic acids. Pharmacological Reviews. ,vol. 45, pp. 309- 379 ,(1993)
Kenneth A. Jacobson, Timothy M. Palmer, Gary L Stiles, Simon M. Poucher, 125I-4-(2-[7-Amino-2-{2-furyl}{1,2,4}triazolo{2,3-a}{1,3,5}triazin-5-yl-amino]ethyl)phenol, a High Affinity Antagonist Radioligand Selective for the A2a Adenosine Receptor Molecular Pharmacology. ,vol. 48, pp. 970- 974 ,(1995)
P.M. Gross, D.F. Weave, R.J. Bowers, S. Nag, L.T. Ho, J.J. Pang, F.J. Espinosa, Neurotoxicity in conscious rats following intraventricular SNAP, a nitric oxide donor Neuropharmacology. ,vol. 33, pp. 915- 927 ,(1994) , 10.1016/0028-3908(94)90190-2
R. E. Simpson, M. H. O'Regan, L. M. Perkins, J. W. Phillis, Excitatory Transmitter Amino Acid Release from the Ischemic Rat Cerebral Cortex: Effects of Adenosine Receptor Agonists and Antagonists Journal of Neurochemistry. ,vol. 58, pp. 1683- 1690 ,(1992) , 10.1111/J.1471-4159.1992.TB10041.X
Stefan Zalavary, Olle Stendahl, Torbjörn Bengtsson, The role of cyclic AMP, calcium and filamentous actin in adenosine modulation of Fc receptor-mediated phagocytosis in human neutrophils Biochimica et Biophysica Acta. ,vol. 1222, pp. 249- 256 ,(1994) , 10.1016/0167-4889(94)90176-7
Chiara Dianzani, Sandra Brunelleschi, Ilario Viano, Roberto Fantozzi, Adenosine modulation of primed human neutrophils European Journal of Pharmacology. ,vol. 263, pp. 223- 226 ,(1994) , 10.1016/0014-2999(94)90547-9
E. Bona, U. Ådén, E. Gilland, B.B. Fredholm, H. Hagberg, Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists. Neuropharmacology. ,vol. 36, pp. 1327- 1338 ,(1997) , 10.1016/S0028-3908(97)00139-1
ENNIO ONGINI, MARINA ADAMI, CINZIA FERRI, ROSALIA BERTORELLI, Adenosine A2A Receptors and Neuroprotection Annals of the New York Academy of Sciences. ,vol. 825, pp. 30- 48 ,(1997) , 10.1111/J.1749-6632.1997.TB48412.X